Delhi Network Of Positive People Opposition, Gsk3036656, (201717032083)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Bedaquiline Long Acting Formulation, (IN202017005443)
Countries: India Date: 2021
-
Delhi Network of Positive People opposition, Lenacapavir, (201917006277)
Countries: India Date: 2021
-
The Delhi Network of Positive People opposition, Glecaprevir / Pibrentasvir, (201817002543)
Countries: India Date: 2021
-
Delhi Network of Positive People (DNP+) opposition, Bedaquiline, Pretomanid and Linezolid, (201817014361)
Countries: India Date: 2020
-
Delhi Network of Positive People (DNP+) opposition, Glecaprevir / Pibrentasvir , (201817002543)
Countries: India Date: 2021
-
Delhi Network of Positive People (DNP+) opposition, Lumacaftor, (3158/KOLNP/2012)
Countries: India Date: 2021
-
Delhi Network of Positive People (DNP+) and Ganesh Acharya opposition, Bedaquiline, (201727030045)
Countries: India Date: 2020
-
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Isoniazid-Rifapentine (3HP), (201637002757)
Countries: India Date: 2019
-
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Isoniazid-Rifapentine (3HP), (201637002758)
Countries: India Date: 2019
-
Delhi Network of Positive People (DNP+) opposition, efavirenz (EFV) , (IN/PCT/2000/00553/MUM (granted as: 195367))
Countries: India Date: 2007